Previous research has indicated that uPAR, especially its soluble form, could serve as a diagnosis and prognosis biomarker in T1DM-related (39), T2DM-related (40), and DM-related complications such as diabetic cardiovascular diseases (41) and DKD (42). This evidence concerns the gene PLAUR and diabetic kidney disease.